Introduction
Moderate-to-severe atopic dermatitis, commonly known as eczema, can have a significant impact on daily life. Persistent itching, inflamed skin, sleep disruption, and recurring flare-ups can affect physical comfort, emotional well-being, and overall quality of life. While topical medications help many people manage symptoms, some patients continue to experience uncontrolled disease despite treatment.
Ebglyss is a prescription biologic medication designed to target a specific inflammatory pathway involved in atopic dermatitis. By blocking interleukin-13 (IL-13), a protein that plays an important role in eczema-related inflammation, Ebglyss helps reduce itching, improve skin symptoms, and support long-term disease control in eligible patients.
Because Ebglyss is a specialty biologic medication, treatment costs can be substantial without adequate insurance coverage or financial assistance. Many individuals researching the Ebglyss patient assistance program are looking for ways to reduce medication expenses while maintaining access to treatment.
Prescription Hope offers patient advocacy support for qualified patients seeking access to affordable medications through patient assistance programs.
What Is the Ebglyss Patient Assistance Program?
Understanding Ebglyss Prescription Assistance
Pharmaceutical manufacturers recognize the financial burden of many brand-name medications’ retail costs.
To help alleviate this pain for struggling Americans, manufacturers often launch patient assistance programs, such as the Ebglyss patient assistance program.
Qualified patients receive access to brand-name medications at low cost.
Unfortunately, patient assistance programs have been known to require extensive documentation, research, and communication with healthcare providers and the manufacturer. This can result in confusion, frustration, and a sense of being overwhelmed by the process.
Prescription Hope can help.
How Expert Advocates Help Make Ebglyss More Affordable
Personalized Medication Assistance
Prescription Hope’s Ebglyss enrollment assistance offers qualified patients access to affordable medication at a fraction of the retail cost of the medication.
Our team of patient advocates understands the difficulty of applying for patient assistance programs, as well as maintaining access long-term. We support you throughout the process, taking care of forms, documents and signatures, communication with healthcare providers, coordinating with manufacturers, and more.
As your prescription assistance specialists, we advocate on your behalf so you can focus on treatment and quality of life.
Ongoing Patient Support
Not only does our team of patient advocates come alongside you throughout the application process, but they continue to provide you with patient-centered support for as long as you are a patient with us.
Our long-term medication assistance includes refill scheduling, document updates, yearly renewals, program monitoring, and more.
Navigating Biologic Medication Costs
While brand-name medications are often extremely expensive out of pocket, there are many ways to save.
However, each one comes with its own drawbacks. Insurance can include high co-pays or deductibles, discount cards and coupons may be limited in savings, and government programs often include large gaps.
Prescription Hope is different. We are not an insurance company, government-affiliated, or a discount card.
We are a medication access service that offers access to affordable medications for a simple $70.00 per month, per medication.
We do not charge you hidden fees, add-ons, or even medication costs.
If you don’t qualify for your intended medication, we’ll work to help you find alternatives, such as substitute medications, discount cards, coupons, or other ways to save.
And if we can’t help you save, then you pay nothing.
Ebglyss Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Ebglyss Patient Assistance Eligibility
General Eligibility Requirements
Those interested in finding out who qualifies for Ebglyss assistance will need to understand prescription assistance requirements. Since all patient assistance programs have approval criteria, patients should know ahead of time whether or not they’re likely to qualify.
Programs typically set requirements in several categories:
Income: Each program sets its own income threshold for qualification.
Insurance: Each program also sets its own insurance coverage status requirements.
Prescription: All patients must have a valid prescription for their intended brand-name medication to qualify.
U.S. Residency: All patients must be legal residents of the United States to qualify.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Ready to enroll in Ebglyss assistance? Looking for medication assistance enrollment?
Prescription Hope’s medication access service takes 6 simple steps:
- Submit Information: Our online enrollment form only takes a few minutes to complete.
- Advocate Contact: Once we receive your enrollment form, a patient advocate will contact you within 1-2 business days.
- Document Collection: After prequalification, our team will collect all necessary documents
- Provider Coordination: Our team will also gather needed signatures from healthcare providers
- Program Submission: Once everything is in order, we submit your application and continue to coordinate with the manufacturer throughout the processing stage.
- Medication Delivery: Following approval, patients typically receive their medication within 2 weeks. All medications ship directly from the manufacturer to the patient’s door or doctor’s office.
Understanding Ebglyss
How Ebglyss Works
Ebglyss is a monoclonal antibody that specifically targets interleukin-13 (IL-13), an inflammatory protein involved in the development and progression of atopic dermatitis. Elevated IL-13 activity contributes to chronic skin inflammation, itching, skin barrier dysfunction, and recurring eczema symptoms.
By binding to and blocking IL-13 signaling, Ebglyss helps interrupt inflammatory processes associated with eczema. This targeted approach helps reduce skin inflammation while supporting improvements in skin barrier function and overall disease control.
Unlike traditional systemic treatments that may broadly suppress immune activity, Ebglyss selectively targets a specific pathway involved in atopic dermatitis.
What Conditions Does Ebglyss Treat?
Ebglyss is FDA-approved for the treatment of moderate-to-severe atopic dermatitis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg (88 pounds) and whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Atopic dermatitis is a chronic inflammatory skin condition characterized by itching, redness, irritation, dry skin, and recurring flare-ups. In moderate-to-severe cases, symptoms may affect large areas of the body and significantly interfere with sleep, work, school, social activities, and daily life.
Healthcare providers may prescribe Ebglyss for patients who continue to experience significant symptoms despite topical treatment or for those who require a systemic treatment option to achieve better disease control. The medication may be used with or without topical corticosteroids and other topical therapies when appropriate.
Benefits of Treatment
Ebglyss provides a targeted treatment option for patients with moderate-to-severe atopic dermatitis who require more than topical therapy alone. By addressing IL-13-driven inflammation, the medication helps improve multiple aspects of eczema.
Potential benefits include reducing itching, improving skin clearance, decreasing inflammation, reducing the frequency of flare-ups, and helping improve sleep disrupted by persistent itching.
Because eczema affects individuals differently, treatment responses vary, and healthcare providers monitor progress throughout therapy to evaluate effectiveness and long-term management.
Important Safety Information and Side Effects
Ebglyss does not carry an FDA Boxed Warning. However, patients should be aware of important safety considerations before and during treatment.
The most commonly reported side effects include conjunctivitis, eye inflammation, injection-site reactions, shingles (herpes zoster), dry eyes, and eye irritation. Most side effects are mild to moderate, although serious adverse reactions can occur.
Serious hypersensitivity reactions, including anaphylaxis, have been reported. Symptoms may include rash, hives, facial swelling, difficulty breathing, and severe allergic reactions. Patients should seek immediate medical attention if signs of a serious allergic reaction develop.
Eye-related complications may occur during treatment. Conjunctivitis, keratitis, dry eye symptoms, and other forms of eye inflammation have been reported more frequently in patients receiving Ebglyss. Patients who develop new or worsening eye symptoms should contact their healthcare provider and may require evaluation by an eye specialist.
Patients with existing parasitic (helminth) infections should receive appropriate treatment before beginning Ebglyss whenever possible. If a patient develops a parasitic infection that does not respond to treatment, healthcare providers may consider temporarily discontinuing Ebglyss until the infection resolves.
Patients should discuss vaccination status with their healthcare provider before starting treatment. Age-appropriate vaccinations should generally be completed prior to therapy when possible, and live vaccines are generally avoided during treatment.
Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss the potential risks and benefits of treatment with their healthcare provider. Limited human pregnancy data are currently available, and it is not known whether lebrikizumab passes into human breast milk.
Although no major drug interactions have been identified, patients should inform their healthcare provider about all prescription medications, over-the-counter products, supplements, and vaccinations before starting treatment.
Healthcare providers may monitor treatment response, severity of itching, skin clearance, injection-site reactions, eye-related symptoms, and signs of hypersensitivity throughout treatment.
Access to Multiple Medications
Support Beyond Ebglyss
Some patients looking for eczema medication support are also looking for multiple medication assistance programs. Thankfully, our specialty medication access service offers qualified patients access to hundreds of brand-name medications.
No matter how many meds you qualify for, we provide the same great service at the same low rate of $70.00 per month, per medication.
Why Choose Prescription Hope for Ebglyss Assistance
Patient-Focused Medication Support
For 20 years, Prescription Hope has provided expert patient advocacy and support for patients across the nation. Our medication access specialists help everyday Americans access the medications they need at low cost.
Simplified Access to Specialty Therapies
Our service rate remains a simple and cost-effective $70.00 per month, per medication. That means no add-ons, hidden charges, or medication costs.
And if we can’t help you find a way to save, then you pay nothing!
Ongoing Prescription Assistance
We don’t just offer access. We provide ongoing management of program administration. This includes refill scheduling, yearly renewals, document updates, program monitoring, and more.
Network Access
Our network extends across America, allowing patients in both rural areas and cities to access the same great affordable medications.
If you’re looking to apply for the Ebglyss Patient Assistance Program, then be sure to enroll with Prescription Hope to get started today!